{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:32Z","timestamp":1790946692477,"version":"4.1.0"},"reference-count":58,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Gaucher disease (GD) is an autosomal recessive lysosomal storage disorder caused by mutations in the acid \u03b2-glucosidase gene (GBA1). Besides causing GD, GBA1 mutations constitute the main genetic risk factor for developing Parkinson\u2019s disease. The molecular basis of neurological manifestations in GD remain elusive. However, neuroinflammation has been proposed as a key player in this process. We exploited CRISPR\/Cas9 technology to edit GBA1 in the human monocytic THP-1 cell line to develop an isogenic GD model of monocytes and in glioblastoma U87 cell lines to generate an isogenic GD model of glial cells. Both edited (GBA1 mutant) cell lines presented low levels of mutant acid \u03b2-glucosidase expression, less than 1% of residual activity and massive accumulation of substrate. Moreover, U87 GBA1 mutant cells showed that the mutant enzyme was retained in the ER and subjected to proteasomal degradation, triggering unfolded protein response (UPR). U87 GBA1 mutant cells displayed an increased production of interleukin-1\u03b2, both with and without inflammosome activation, \u03b1-syn accumulation and a higher rate of cell death in comparison with wild-type cells. In conclusion, we developed reliable, isogenic, and easy-to-handle cellular models of GD obtained from commercially accessible cells to be employed in GD pathophysiology studies and high-throughput drug screenings.<\/jats:p>","DOI":"10.3390\/ijms21093268","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T03:10:38Z","timestamp":1588821038000},"page":"3268","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["CRISPR\/Cas9 Editing for Gaucher Disease Modelling"],"prefix":"10.3390","volume":"21","author":[{"given":"Eleonora","family":"Pavan","sequence":"first","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, Academic Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Ormazabal","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, Academic Hospital of Udine, 33100 Udine, Italy"},{"name":"Departamento de Ciencias Biol\u00f3gicas, IIFP, Universidad Nacional de La Plata, CONICET, Facultad de Ciencias Exactas Bv120 Nro.1489, La Plata 1900, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Peruzzo","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, Academic Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Vaena","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biol\u00f3gicas, IIFP, Universidad Nacional de La Plata, CONICET, Facultad de Ciencias Exactas Bv120 Nro.1489, La Plata 1900, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Rozenfeld","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biol\u00f3gicas, IIFP, Universidad Nacional de La Plata, CONICET, Facultad de Ciencias Exactas Bv120 Nro.1489, La Plata 1900, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7024-8181","authenticated-orcid":false,"given":"Andrea","family":"Dardis","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, Academic Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebroside. Evidence of an enzymatic deficiency in Gaucher\u2019s disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","article-title":"Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease","volume":"39","author":"Nilsson","year":"1982","journal-title":"J. Neurochem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0950-3536(97)80037-6","article-title":"Gaucher\u2019s Disease. Pathological features","volume":"10","author":"Pastores","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"ref_4","unstructured":"Scriver, C.R., Beaudet, A.L., Valle, D., and Sly, W.S. (2001). Gaucher disease. The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill."},{"key":"ref_5","first-page":"157","article-title":"Clinical manifestations and management of Gaucher disease","volume":"12","author":"Linari","year":"2015","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_6","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Stephens, K., and Amemiya, A. (2000). Gaucher Disease. GeneReviews\u00ae [Internet], University of Washington."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., and Brassier, A. (2017). A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020441"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-7091-1511-4_20","article-title":"Neuronal forms of Gaucher disease","volume":"216","author":"Vitner","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/hmg\/ddp061","article-title":"No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease","volume":"18","author":"Vitner","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_12","first-page":"205","article-title":"Cytokines in Gaucher\u2019s disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3346\/jkms.2006.21.4.733","article-title":"Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse","volume":"21","author":"Hong","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/brain\/aws095","article-title":"Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher\u2019s disease","volume":"135","author":"Vitner","year":"2012","journal-title":"Brain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jnc.13385","article-title":"The relationship between glucocerebrosidase mutations and Parkinson disease","volume":"139","author":"Schapira","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/febs.14393","article-title":"The role of glucocerebrosidase in Parkinson disease pathogenesis","volume":"285","author":"Gegg","year":"2018","journal-title":"FEBS J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"a020628","DOI":"10.1101\/cshperspect.a020628","article-title":"Astrocytes in neurodegenerative disease","volume":"7","author":"Phatnani","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainresbull.2017.02.001","article-title":"Human astrocytes in the diseased brain","volume":"136","author":"Dossi","year":"2018","journal-title":"Brain Res. Bull."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sung, K., and Jimenez-Sanchez, M. (2020). Autophagy in astrocytes and its implications in neurodegeneration. J. Mol. Biol., in press.","DOI":"10.1016\/j.jmb.2019.12.041"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"104647","DOI":"10.1016\/j.nbd.2019.104647","article-title":"A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson\u2019s disease","volume":"134","author":"Aflaki","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_21","first-page":"295","article-title":"Applications of iPSC-derived models of Gaucher disease","volume":"3","author":"Borger","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"ref_22","first-page":"e712","article-title":"New macrophage models of Gaucher disease offer new tools for drug development","volume":"2","author":"Borger","year":"2015","journal-title":"Macrophage"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Santos, R., and Amaral, O. (2019). Advances in sphingolipidoses: CRISPR-Cas9 editing as an option for modelling and therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235897"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuron.2017.01.018","article-title":"The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease","volume":"93","author":"Aflaki","year":"2017","journal-title":"Neuron"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00017-19","DOI":"10.1128\/JVI.00017-19","article-title":"Glucosylceramidase Maintains Influenza Virus Infection by Regulating Endocytosis","volume":"93","author":"Drews","year":"2019","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: An in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02041244","article-title":"The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation","volume":"47","author":"Auwerx","year":"1991","journal-title":"Experientia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: Formation of glycosphingoid bases during deficiency of glycosidases","volume":"590","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Allen, M., Bjerke, M., Edlund, H., Nelander, S., and Westermark, B. (2016). Origin of the U87MG glioma cell line: Good news and bad news. Sci. Transl. Med., 8.","DOI":"10.1126\/scitranslmed.aaf6853"},{"key":"ref_31","unstructured":"Berger, M.S., and Weller, M. (2016). Glioblastoma. Gliomas (Handbook of Clinical Neurology (Volume 134)), Elsevier."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.neuro.051508.135600","article-title":"The glial nature of embryonic and adult neural stem cells","volume":"32","author":"Kriegstein","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1161\/ATVBAHA.117.310023","article-title":"CRISPR\/Cas9-Mediated Gene Editing in Human iPSC-Derived Macrophage Reveals Lysosomal Acid Lipase Function in Human Macrophages-Brief Report","volume":"37","author":"Zhang","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/humu.22124","article-title":"Gaucher disease paradigm: From ERAD to comorbidity","volume":"33","author":"Horowitz","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/stem.1732","article-title":"Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development","volume":"32","author":"Panicker","year":"2014","journal-title":"Stem Cells"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bondar, C., Ormazabal, M., Crivaro, A., Ferreyra-Compagnucci, M., Delpino, M., Rozenfeld, P.A., and Mucci, J.M. (2017). Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010112"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cabasso, O., Paul, S., Dorot, O., Maor, G., Krivoruk, O., Pasmanik-Chor, M., Mirzaian, M., Ferraz, M., Aerts, J., and Horowitz, M. (2019). Drosophila melanogaster Mutated in its GBA1b Ortholog Recapitulates Neuronopathic Gaucher Disease. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091420"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/hmg\/ddz005","article-title":"The effect of mutant GBA1 on accumulation and aggregation of \u03b1-synuclein","volume":"28","author":"Maor","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Aflaki, E., Stubblefield, B.K., Maniwang, E., Lopez, G., Moaven, N., Goldin, E., Marugan, J., Patnaik, S., Dutra, A., and Southall, N. (2014). Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs. Sci. Transl. Med., 6.","DOI":"10.1126\/scitranslmed.3008659"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Sun, Y., Florer, J., Mayhew, C.N., Jia, Z., Zhao, Z., Xu, K., Ran, H., Liou, B., Zhang, W., and Setchell, K.D. (2015). Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: Potential role in neuropathology. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118771"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","article-title":"A New Glucocerebrosidase Chaperone Reduces \u03b1-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism","volume":"36","author":"Aflaki","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","article-title":"Induced Pluripotent Stem Cells Meet Genome Editing","volume":"18","author":"Hockemeyer","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Doss, M.X., and Sachinidis, A. (2019). Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. Cells, 8.","DOI":"10.3390\/cells8050403"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/hmg\/ddm324","article-title":"ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones","volume":"17","author":"Wei","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"Mu","year":"2008","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1750-1172-8-140","article-title":"Unfolded protein response in Gaucher disease: From human to Drosophila","volume":"8","author":"Maor","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bcmd.2016.10.025","article-title":"UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease","volume":"68","author":"Braunstein","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","article-title":"RIPK3 as a potential therapeutic target for Gaucher\u2019s disease","volume":"20","author":"Vitner","year":"2014","journal-title":"Nat. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocerebrosidase mutations and parkinsonism","volume":"17","author":"Westbroek","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson\u2019s disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fimmu.2020.00033","article-title":"Molecular Signatures of Neuroinflammation Induced by \u03b1Synuclein Aggregates in Microglial Cells","volume":"11","author":"Sarkar","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: A vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Crivaro, A.N., Mucci, J.M., Bondar, C.M., Ormazabal, M.E., Ceci, R., Simonaro, C., and Rozenfeld, P.A. (2019). Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217780"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/9\/3268\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:09:57Z","timestamp":1760364597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/9\/3268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["ijms21093268"],"URL":"https:\/\/doi.org\/10.3390\/ijms21093268","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]}}}